NFE2L2 and diabetes mellitus: Furthermore, the butyrate-mediated inhibition of HDAC increases nuclear factor erythroid 2-related factor 2 (Nrf2) expression via the coactivator P300 at the Nrf2 promoter [46], which has been shown to lead to an increase of its downstream targets to protect against diabetes-induced oxidative stress and inflammation in diabetic mice [47].